BEIJING (Reuters) - Chinese President Xi Jinping warned that the world’s second-biggest economy is facing a period of ‘turbulent change’ and that rising external markets risk required policymakers to increasingly rely on domestic demand to spur growth.

Xi, chairing a seminar

KENOSHA, Wis. (Reuters) - The family of the Black man shot by police in Kenosha, Wisconsin, made an emotional plea for the value of their son’s life on Tuesday and called for an end to the violent protests that erupted in the city.

“They shot my son seven times. Seven times! Like he didn’t matter,” Jacob Blake Sr., his voice crumbling with emotion told a news conference following the Sunday shooting of his 29-year-old son. “

LONDON (Reuters) - Trial data for the University of Oxford and AstraZeneca’s possible coronavirus vaccine could be given to regulators this year but corners cannot be cut to speed up approval for emergency use, a scientist leading the trials said on Tuesday.

The Oxford vaccine produced an immune

COPENHAGEN (Reuters) - Danske Bank ( DANSKE.CO ) said on Tuesday that Jakob Groot, a member of the bank’s executive team and head of its Corporate & Institutions unit, will leave the bank as part of an organisational change.

Under the restructuring, commercial activities will be organised in two business units - one serving retail customers and small and medium-

SEOUL (Reuters) - Tesla Inc ( TSLA.O ) CEO Elon Musk has suggested the U.S. electric carmaker may be able to mass produce batteries with 50% more energy density in three to four years, which could even enable electric airplanes.

His comments came as speculation is growing about announcements at Tesla’

AMSTERDAM/BRUSSELS (Reuters) - Two European patients are confirmed to have been re-infected with COVID-19, raising concerns about people’s immunity to the coronavirus as the world struggles to tame the pandemic.

The

(Reuters) - British drugmaker AstraZeneca ( AZN.L ) has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus.

The London-listed firm, already among the leading players in the global race to develop a successful vaccine, said the study would evaluate if AZD7442, a combination of two monoclonal antibodies (mAbs), was safe and tolerable in up to

(Reuters) - British industrial software provider Aveva Group is buying SoftBank-backed peer OSIsoft for an enterprise value of $5 billion, it said on Tuesday, as it seeks to expand its services with the California-based firm’s PI system.

The deal will see Japanese tech conglomerate Softbank - which has embarked on an asset sales plan - sell its 44.7% stake in OSIsoft for more than $2 billion in cash, James Kidd, deputy CEO and CFO of Aveva, told Reuters in a

BERLIN (Reuters) - The German economy contracted by a record 9.7% in the second quarter as consumer spending, company investments and exports all collapsed at the height of the COVID-19 pandemic, the statistics office said on Tuesday.

The economic slump was much stronger than during the financial crisis more than a decade ago, and it represented the sharpest decline since Germany began to record quarterly GDP calculations in 1970, the office said.

Still, the reading marked a minor upward revision from an